Favtris (Favipiravir) Tablet

Generic brands for Favipiravir Injection  Available in India Brand Name Favtris Generic Name Favipiravir Strength 400mg, 800mg Manufacturer Mylan Pharmaceuticals Pvt. Ltd

Description

Description

This page contains brief details about the drug favipiravir, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.

Date of Approval

The U.S. FDA-approved Favipiravir to treat people with influenza and other viral infections, including Covid-19.

Mechanism of Action of Favipiravir

Favipiravir tablet metabolizes to ribosyl triphosphate and converts into its active form called Favipiravir-RTP, and it works by inhibiting the activity of the enzyme  (RNA polymerase) that is necessary for viral replication. It works by stopping the replication of the infection-causing virus in the body.

Uses of Favipiravir

Favipiravir tablet is an Antiviral drug that belongs to the medication class known as Pyrazinecarboxamide derivative.  It is used to treat influenza and other viral infections, including Covid-19.

Favipiravir Dosage available

Take Favipiravir as advised by your physician. Do not crush, chew, or open the medicine. Your physician will decide the correct dosage and duration based on age, body weight, and disease condition. Only stop taking the tablet if your doctor advises you to stop.

We can ship to :

News/Updates

References

  1. U Agrawal et al, Favipiravir: A new and emerging antiviral option in Covid 19, [Revised on 2020] [Accessed on 09th Apr 2023], https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467067/pdf/main.pdf
  2. Ghasemnejad-Berenji M, Pashapour S. Favipiravir and COVID-19: A. Drug Res, 2021, 71: 166–170 [Accessed on 09th Apr 2023],  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043595/pdf/10-1055-a-1296-7935.pdf
  3. Y Furuta, Favipiravir (T-705), a broad-spectrum inhibitor of viral RNA Polymerase, Proc Jpn Acad Ser B Phys Biol Sci, 2017, 93(7):449-463 [Accessed on 09th Apr 2023], https://pubmed.ncbi.nlm.nih.gov/28769016/
  4. Ciplamed, [Revised on 27th Nov 2020] [Accessed on 09th Apr 2023], https://www.ciplamed.com/content/ciplenza-tablets